BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22125876)

  • 1. Modern oncologic and operative outcomes for oesophageal cancer treated with curative intent.
    Reynolds JV; McGillycuddy E; Ravi N; Donohoe C; O'Toole D; O'Byrne K; Hollywood D
    Ir Med J; 2011 Sep; 104(8):235-8. PubMed ID: 22125876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
    Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
    Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
    Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
    Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
    Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
    Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality treatment for esophageal malignancy: the roles of surgery and neoadjuvant therapy.
    Malin E; Kiernan PD; Sheridan MJ; Khandhar SJ; Fraser C; Hetrick V
    Am Surg; 2009 Jun; 75(6):489-97. PubMed ID: 19545097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
    Morgan MA; Lewis WG; Casbard A; Roberts SA; Adams R; Clark GW; Havard TJ; Crosby TD
    Br J Surg; 2009 Nov; 96(11):1300-7. PubMed ID: 19847875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
    Girvin GW; Matsumoto GH; Bates DM; Garcia JM; Clyde JC; Lin PH
    Am J Surg; 1995 May; 169(5):557-9. PubMed ID: 7747839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
    Bower M; Jones W; Vessels B; Scoggins C; Martin R
    Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL; Ho JW; Chan R; Au G; Chu KW
    Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
    Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Result of surgery of esophageal cancer. Analysis of a series of 349 cases based on resection methods].
    Dumont P; Wihlm JM; Roeslin N; Massard G; Lion R; Morand G
    Ann Chir; 1993; 47(8):773-83. PubMed ID: 8311412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction treatment of locally advanced operable cancers of the esophagus. Prognostic significance of the histologic response].
    Thomas P; Doddoli C; Giacoia A; Garbe L; Perrier H; Giovannini M; Seitz JF; Hannoun-Levi JM; Giudicelli R; Fuentes P
    Ann Chir; 1997; 51(3):222-31. PubMed ID: 9297883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.